-
ALSO READ
Japan reports first case of new Covid strain that emerged in South Africa
BioNTech CEO confident Covid-19 vaccine will work on new UK variant
Three test positive for the new UK variant of coronavirus in Rajasthan
Five more cases of new Covid-19 variant found in India, total at 25
2-year-old UK returnee tests positive for new coronavirus strain in UP
-
The central government said on Tuesday that 20 more cases of mutant strain of coronavirus reported from UK have been detected in India, taking the total such cases in the country to 58.
"All these persons have been kept in single-room isolation in designated healthcare facilities by the respective state governments. Their close contacts have also been put in quarantine. Comprehensive contact tracing has been initiated for co-travellers, family contacts and others. Genome sequencing on other specimens is going on," the Health Ministry said.
Of these total cases, eight have been registered at the National Centre for Disease Control (NCDC), 11 at CSIR Institute of Genomics and Integrative Biology (IGIB), (both in Delhi), and 10 at National Institute of Mental Health and Neuro-Sciences (NIMHANS) in Bengaluru.
Three such cases have been detected at Cellular and Molecular Biology in Hyderabad, one at National Institute of Biomedical Genomics in West Bengal, and 25 at National Institute of Virology, Pune.
On December 29, six UK returnees were found positive for the new coronavirus variant. These were the first cases to be reported in India, which has the second highest number of coronavirus cases after the United States.
The tracing and testing was initiated after the British government announced that a newly identified strain of the virus was found in the UK population, which is up to 70 per cent more transmissible.
Notably, the UK strain has already been reported by Denmark, Netherlands, Australia, Italy, Sweden, France, Spain, Switzerland, Germany, Canada, Japan, Lebanon and Singapore.
The Ministry said that it is monitoring the situation closely and giving regular advice to the states for enhanced surveillance, containment, testing and dispatch of samples to labs.
--IANS
aka/tsb
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU